logo
Sign in

CEL Stock Price, Chart, Stats & News

Celadon Pharmaceuticals Plc
Save

Celadon Pharmaceuticals Plc (CEL) does not currently pay a dividend.

9.23M
Market cap
Current P/E
Forward P/E

CEL chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

Celadon Pharmaceuticals Plc functions as a drug development company, concentrating on the discovery, production, and distribution of cannabinoid compounds for certified medical uses. The firm's primary activity involves the indoor, hydroponic cultivation of THC cannabis, which is then incorporated into medicinal products targeting chronic pain. Furthermore, Celadon intends to broaden its research into cannabinoids, exploring their therapeutic applications not only for persistent pain but also for conditions such as autism and multiple sclerosis.

Similar securities

Based on sector and market capitalization

Report issue